|
Volumn 26, Issue 3, 1998, Pages 369-381
|
Continuing education Varicella-zoster virus: Infection, control, and prevention
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ACICLOVIR;
ANTIHISTAMINIC AGENT;
DIPHENHYDRAMINE;
HERPES ZOSTER IMMUNOGLOBULIN;
OKA MERCK;
OKA MERCK VACCINE;
UNCLASSIFIED DRUG;
VARICELLA ZOSTER VACCINE;
CHICKENPOX VACCINE;
CHICKENPOX;
CHILDHOOD DISEASE;
DRUG COST;
HERPES ZOSTER;
HUMAN;
IMMUNE DEFICIENCY;
INFECTION CONTROL;
INJECTION PAIN;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LATENT VIRUS INFECTION;
ORAL DRUG ADMINISTRATION;
REVIEW;
SKIN DEFECT;
VARICELLA ZOSTER VIRUS;
VIRUS TRANSMISSION;
ADULT;
CHILD;
CROSS INFECTION;
FEMALE;
HOSPITAL PERSONNEL;
PREGNANCY;
ADULT;
CHICKENPOX;
CHICKENPOX VACCINE;
CHILD;
CROSS INFECTION;
FEMALE;
HERPES ZOSTER;
HERPESVIRUS 3, HUMAN;
HUMANS;
PERSONNEL, HOSPITAL;
PREGNANCY;
|
EID: 0032086822
PISSN: 01966553
EISSN: None
Source Type: Journal
DOI: 10.1016/S0196-6553(98)80025-4 Document Type: Article |
Times cited : (27)
|
References (120)
|